Biotech Analyst Watsek and Biopharma & Biotech Analyst Chen, along with Associate Professor of Medical Oncology at UC San Diego, Dr. Husain, provide takeaways on key themes and clinical data (relevant companies ANVN BGNE RCUS JNJ AMAM IMAB) from the 2023 European Society for Medical Oncology (ESMO) Annual Meeting on an Analyst/Industry conference call to be held on October 25 at 1 pm. Webcast Link
Published first on TheFly – the ultimate source for real-time, market-moving breaking financial news. Try Now>>
See the top stocks recommended by analysts >>
Read More on ARVN:
- Cantor biotech/biopharma analysts hold an analyst/industry conference call
- Arvinas price target lowered to $52 from $62 at BofA
- Arvinas price target lowered to $36 from $72 at Citi
- Arvinas price target lowered to $26 from $39 at Barclays
- Wedbush upgrades Arvinas to Outperform on potential of ARV-766